
Indivumed: A global biopharma partner specializing in individualized cancer therapy and biologic sample analysis.
Official pages and third-party coverage in one index.
indivumed-therapeutics.com21 items across 20 mapped pages · Crawled Sep 24, 2026
Official pages and third-party coverage in one index
It has been a very special year – with unexpected challenges and global uncertainty putting much of the world at a standstill. With this in mind, we are grateful and proud to look back and see that Indivumed did not stand still – in the face of these challenges, we kept moving forward.
We are pleased to share this article published in LaBiotech, which provides insights into how our data-driven approach is setting new standards in cancer treatment for solid tumors.
Read our at MDPI newly published paper on "Applied Molecular-Based Quality Control of Biobanked Samples for Multi-Omics Approach".
Biotechnology has developed into a central driver of medical innovation in life science hotspot Northern Germany.
We are pleased to again be featured in the BIO Deutschland Yearbook for 2023/2024 and proud to be a part of the rapidly growing European biotech industry, looking forward to continuing our success in 2024. Read our feature interview and profile here.
Explore the latest company news, insights, scientific publications and media coverage.
Join us in shaping the path to precision cancer therapy.
We believe that every cancer patient deserves targeted drugs tailored to their specific disease as closely as possible.
Through the Indivumed Global Clinical Network, we utilize a highly standardized collection process for biospecimens and patient information.
Indivumed discovers novel targets for the development of precision cancer therapeutics.
Onco AI-Med is a collaborative network of leading oncologists and cancer researchers.
If you have any questions or you want to become part of our clinical network, please do not hesitate to get in touch. We look forward to hearing from you.
If you would like to learn more about Indivumed or for any questions about joining our team, please do not hesitate to get in touch. We look forward to hearing from you.
We discover novel targets for the development of precision cancer therapeutics.
We discover novel targets for the development of precision cancer therapeutics.